Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol with Cisplatin and Docetaxel in Advanced NSCLC
NCT00794547Phase 2Terminated
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Dec 2008
- Primary completion
- Oct 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of calcitriol in non-small cell lung cancer (NSCLC), sponsored by University of Michigan Rogel Cancer Center. Started Dec 2008; status: terminated.
02
Drugs
calcitriol
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00794547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794547.